Media

Vivet Therapeutics to Present Key Findings on its Gene Therapy Program forCerebrotendinous Xanthomatosis at the American Association for the Study of Liver Diseases Annual Meeting

Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

HelloBetter Unlocks New Funding to Accelerate AI Product Development

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Oncopeptides publishes Q3 report 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Vicore Pharma – Interim report July-September 2024

Oncopeptides – Invitation to presentation of the Q3 report 2024